{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:32:26Z","timestamp":1794375146209,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003516","name":"Winn Feline Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003516","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The ability of mesenchymal stem cells (MSCs) to modulate immune responses inspired a series of clinical trials addressing oral mucosal inflammation. We previously reported on the safety and efficacy of fresh, allogeneic and autologous, adipose-derived mesenchymal stem cells (ASCs) to treat feline gingivostomatitis (FCGS), an oral mucosal inflammatory disease that shares similarities with human oral lichen planus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To meet clinical demand and goals for future commercialization, we determined the feasibility of shipping fresh ASCs to distant clinics and extended our pilot studies to expand safety and efficacy data for shipped and non-shipped ASCs in a cohort of 18 FCGS cats enrolled locally and at a few different locations within the USA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that ASCs retained their viability, phenotype, and function after shipment. ASCs administered systemically resulted in a 72% positive response rate, identical to that noted in our previous studies. Cats that responded to ASC therapy had a significant decrease in circulating globulin concentration and histological evidence of decreased CD3+ T cells and CD20+ B cells in the oral mucosa. Responder cats also had significantly decreased percentages of CD8\n                      <jats:sup>lo<\/jats:sup>\n                      cells in blood prior to and at 3\u2009months post-ASC therapy. CD8\n                      <jats:sup>lo<\/jats:sup>\n                      cells may serve as a potential \u201cpredictor\u201d for response to systemic ASC therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Fresh feline ASCs can be successfully shipped and administered to cats with FCGS. ASCs modulate the immune response and demonstrate efficacy for chronic oral mucosal inflammatory lesions that are characterized by CD8+ T cell inflammation and T cell activation. FCGS is a potentially useful naturally occurring large animal model of human oral inflammatory diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-020-01623-9","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T10:04:26Z","timestamp":1584093866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["A multicenter experience using adipose-derived mesenchymal stem cell therapy for cats with chronic, non-responsive gingivostomatitis"],"prefix":"10.1186","volume":"11","author":[{"given":"Boaz","family":"Arzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Fiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Vapniarsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nopmanee","family":"Taechangam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubaldo","family":"Delatorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin C.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan R.","family":"Loscar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milinda J.","family":"Lommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Battig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dori L.","family":"Borjesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,13]]},"reference":[{"issue":"1","key":"1623_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","volume":"17","author":"A Trounson","year":"2015","unstructured":"Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell. 2015;17(1):11\u201322.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"1623_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1742-7843.2004.pto950502.x","volume":"95","author":"M Kassem","year":"2004","unstructured":"Kassem M, Kristiansen M, Abdallah BM. Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol. 2004;95(5):209\u201314.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1623_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.autrev.2011.01.005","volume":"10","author":"E Ben-Ami","year":"2011","unstructured":"Ben-Ami E, Berrih-Aknin S, Miller A. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases. Autoimmun Rev. 2011;10:410\u20135.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"1623_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, et al. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107(1):367\u201372.","journal-title":"Blood."},{"issue":"1","key":"1623_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1465-3249(05)70787-8","volume":"7","author":"K Le Blanc","year":"2005","unstructured":"Le Blanc K, Pittenger MF. Mesenchymal stem cells: progress toward promise. Cytotherapy. 2005;7(1):36\u201345.","journal-title":"Cytotherapy."},{"issue":"2","key":"1623_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cveq.2011.06.003","volume":"27","author":"JF Peroni","year":"2011","unstructured":"Peroni JF, Borjesson DL. Anti-inflammatory and immunomodulatory activities of stem cells. Vet Clin N Am Equine Pract. 2011;27(2):351\u201362.","journal-title":"Vet Clin N Am Equine Pract"},{"issue":"1","key":"1623_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","volume":"6","author":"NG Singer","year":"2011","unstructured":"Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Ann Rev Pathol. 2011;6(1):457\u201378.","journal-title":"Ann Rev Pathol"},{"issue":"10","key":"1623_CR8","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","volume":"21","author":"S Viswanathan","year":"2019","unstructured":"Viswanathan S, Shi Y, Galipeau J, Krampera M, Leblanc K, Martin I, et al. Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT(R)) Mesenchymal stromal cell committee position statement on nomenclature. Cytotherapy. 2019;21(10):1019\u201324.","journal-title":"Cytotherapy."},{"issue":"4","key":"1623_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","volume":"13","author":"ME Bernardo","year":"2013","unstructured":"Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell. 2013;13(4):392\u2013402.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"1623_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1089\/jop.2011.0166","volume":"28","author":"JA Wood","year":"2012","unstructured":"Wood JA, Chung D-J, Park SA, Zwingenberger AL, Reilly CM, Ly I, et al. Peri-ocular and intra-articular injection of canine adipose derived mesenchymal stem cells: an in vivo imaging and migration study. J Ocul Pharmacol Ther. 2012;28(3):307\u201317.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"1623_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1634\/stemcells.2005-0008","volume":"24","author":"M Krampera","year":"2006","unstructured":"Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2006;24(2):386\u201398.","journal-title":"Stem Cells"},{"issue":"8","key":"1623_CR12","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","volume":"76","author":"I Rasmusson","year":"2003","unstructured":"Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation. 2003;76(8):1208\u201313.","journal-title":"Transplantation."},{"issue":"2","key":"1623_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1365-2249.2007.03422.x","volume":"149","author":"JM Ryan","year":"2007","unstructured":"Ryan JM, Barry F, Murphy JM, Mahon BP. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol. 2007;149(2):353\u201363.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1623_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13287-019-1300-3","volume":"10","author":"N Taechangam","year":"2019","unstructured":"Taechangam N, Iyer SS, Walker NJ, Arzi B, Borjesson DL. Mechanisms utilized by feline adipose-derived mesenchymal stem cells to inhibit T lymphocyte proliferation. Stem Cell Res Ther. 2019;10(1):188.","journal-title":"Stem Cell Res Ther"},{"issue":"308","key":"1623_CR15","doi-asserted-by":"publisher","first-page":"308ps21","DOI":"10.1126\/scitranslmed.aaa9116","volume":"7","author":"A Kol","year":"2015","unstructured":"Kol A, Arzi B, Athanasiou KA, Farmer DL, Nolta JA, Rebhun RB, et al. Companion animals: translational scientist\u2019s new best friends. Sci Transl Med. 2015;7(308):308ps21.","journal-title":"Sci Transl Med"},{"issue":"3","key":"1623_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.stem.2013.01.004","volume":"12","author":"J Cibelli","year":"2013","unstructured":"Cibelli J, Emborg ME, Prockop DJ, Roberts M, Schatten G, Rao M, et al. Strategies for improving animal models for regenerative medicine. Cell Stem Cell. 2013;12(3):271\u20134.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1623_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.critrevonc.2013.03.005","volume":"88","author":"G Ranieri","year":"2013","unstructured":"Ranieri G, Gadaleta CD, Patruno R, Zizzo N, Daidone MG, Hansson MG, et al. A model of study for human cancer: spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies. Crit Rev Oncol Hematol. 2013;88(1):187\u201397.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"1623_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrc2273","volume":"8","author":"M Paoloni","year":"2008","unstructured":"Paoloni M, Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer. 2008;8(2):147\u201356.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1623_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1034\/j.1399-302X.2003.00033.x","volume":"18","author":"MJ Lommer","year":"2003","unstructured":"Lommer MJ, Verstraete FJ. Concurrent oral shedding of feline calicivirus and feline herpesvirus 1 in cats with chronic gingivostomatitis. Oral Microbiol Immunol. 2003;18(2):131\u20134.","journal-title":"Oral Microbiol Immunol"},{"key":"1623_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fvets.2017.00209","volume":"4","author":"I Druet","year":"2017","unstructured":"Druet I, Hennet P. Relationship between feline calicivirus load, oral lesions, and outcome in feline chronic gingivostomatitis (caudal stomatitis): retrospective study in 104 cats. Front Vet Sci. 2017;4:209.","journal-title":"Front Vet Sci"},{"issue":"8","key":"1623_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jfms.2011.05.012","volume":"13","author":"PR Hennet","year":"2011","unstructured":"Hennet PR, Camy GA, McGahie DM, Albouy MV. Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: a randomised, multi-centre, controlled, double-blind study in 39 cats. J Feline Med Surg. 2011;13(8):577\u201387.","journal-title":"J Feline Med Surg."},{"issue":"1","key":"1623_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5966\/sctm.2015-0127","volume":"5","author":"B Arzi","year":"2016","unstructured":"Arzi B, Mills-Ko E, Verstraete FJ, Kol A, Walker NJ, Badgley MR, et al. Therapeutic efficacy of fresh, autologous mesenchymal stem cells for severe refractory gingivostomatitis in cats. Stem Cells Transl Med. 2016;5(1):75\u201386.","journal-title":"Stem Cells Transl Med"},{"issue":"8","key":"1623_CR23","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/sctm.17-0035","volume":"6","author":"B Arzi","year":"2017","unstructured":"Arzi B, Clark KC, Sundaram A, Spriet M, Verstraete FJM, Walker NJ, et al. Therapeutic efficacy of fresh, allogeneic mesenchymal stem cells for severe refractory feline chronic gingivostomatitis. Stem Cells Transl Med. 2017;6(8):1710\u201322.","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"1623_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/1098612X16628578","volume":"19","author":"VM Rolim","year":"2017","unstructured":"Rolim VM, Pavarini SP, Campos FS, Pignone V, Faraco C, Muccillo MS, et al. Clinical, pathological, immunohistochemical and molecular characterization of feline chronic gingivostomatitis. J Feline Med Surg. 2017;19(4):403\u20139.","journal-title":"J Feline Med Surg"},{"issue":"12","key":"1623_CR25","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1097\/CCM.0b013e3181bc7bd5","volume":"37","author":"R Bellomo","year":"2009","unstructured":"Bellomo R, Warrillow SJ, Reade MC. Why we should be wary of single-center trials. Crit Care Med. 2009;37(12):3114\u20139.","journal-title":"Crit Care Med"},{"issue":"6","key":"1623_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/00005650-200106000-00010","volume":"39","author":"M Weinberger","year":"2001","unstructured":"Weinberger M, Oddone EZ, Henderson WG, Smith DM, Huey J, Giobbie-Hurder A, et al. Multisite randomized controlled trials in health services research: scientific challenges and operational issues. Med Care. 2001;39(6):627\u201334.","journal-title":"Med Care"},{"issue":"19","key":"1623_CR27","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1001\/jama.1984.03350190041017","volume":"252","author":"MS Kramer","year":"1984","unstructured":"Kramer MS, Shapiro SH. Scientific challenges in the application of randomized trials. JAMA. 1984;252(19):2739\u201345.","journal-title":"JAMA."},{"issue":"2","key":"1623_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/ije\/dyh162","volume":"33","author":"I Chalmers","year":"2004","unstructured":"Chalmers I, Clarke M. Commentary: the 1944 patulin trial: the first properly controlled multicentre trial conducted under the aegis of the British Medical Research Council. Int J Epidemiol. 2004;33(2):253\u201360.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"1623_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/PRS.0b013e3181df64fa","volume":"126","author":"KC Chung","year":"2010","unstructured":"Chung KC, Song JW, Group WS. A guide to organizing a multicenter clinical trial. Plast Reconstr Surg. 2010;126(2):515\u201323.","journal-title":"Plast Reconstr Surg"},{"issue":"7","key":"1623_CR30","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1089\/scd.2014.0317","volume":"24","author":"B Arzi","year":"2015","unstructured":"Arzi B, Kol A, Murphy B, Walker NJ, Wood JA, Clark K, et al. Feline foamy virus adversely affects feline mesenchymal stem cell culture and expansion: implications for animal model development. Stem Cells Dev. 2015;24(7):814\u201323.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"1623_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3727\/215517912X647217","volume":"4","author":"DD Carrade","year":"2012","unstructured":"Carrade DD, Lame MW, Kent MS, Clark KC, Walker NJ, Borjesson DL. Comparative analysis of the immunomodulatory properties of equine adult-derived mesenchymal stem cells. Cell Med. 2012;4(1):1\u201311.","journal-title":"Cell Med"},{"issue":"1","key":"1623_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/089875641303000101","volume":"30","author":"MJ Lommer","year":"2013","unstructured":"Lommer MJ. Efficacy of cyclosporine for chronic, refractory stomatitis in cats: a randomized, placebo-controlled, double-blinded clinical study. J Vet Dent. 2013;30(1):8\u201317.","journal-title":"J Vet Dent"},{"issue":"2","key":"1623_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.archoralbio.2009.11.004","volume":"55","author":"B Arzi","year":"2010","unstructured":"Arzi B, Murphy B, Cox DP, Vapniarsky N, Kass PH, Verstraete FJ. Presence and quantification of mast cells in the gingiva of cats with tooth resorption, periodontitis and chronic stomatitis. Arch Oral Biol. 2010;55(2):148\u201354.","journal-title":"Arch Oral Biol"},{"issue":"1","key":"1623_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1439-0264.2010.01031.x","volume":"40","author":"B Arzi","year":"2011","unstructured":"Arzi B, Murphy B, Baumgarth N, Vapniarsky N, Nemec A, Naydan DK, et al. Analysis of immune cells within the healthy oral mucosa of specific pathogen-free cats. Anat Histol Embryol. 2011;40(1):1\u201310.","journal-title":"Anat Histol Embryol"},{"issue":"6","key":"1623_CR35","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.injury.2018.04.005","volume":"49","author":"O Wittig","year":"2018","unstructured":"Wittig O, Diaz-Solano D, Cardier J. Viability and functionality of mesenchymal stromal cells loaded on collagen microspheres and incorporated into plasma clots for orthopaedic application: effect of storage conditions. Injury. 2018;49(6):1052\u20137.","journal-title":"Injury."},{"key":"1623_CR36","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1038\/emm.2013.94","volume":"45","author":"MB Murphy","year":"2013","unstructured":"Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013;45:e54.","journal-title":"Exp Mol Med"},{"key":"1623_CR37","doi-asserted-by":"publisher","first-page":"951512","DOI":"10.1155\/2014\/951512","volume":"2014","author":"C Ikebe","year":"2014","unstructured":"Ikebe C, Suzuki K. Mesenchymal stem cells for regenerative therapy: optimization of cell preparation protocols. Biomed Res Int. 2014;2014:951512.","journal-title":"Biomed Res Int"},{"issue":"5","key":"1623_CR38","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/trf.12421","volume":"54","author":"RR Sharma","year":"2014","unstructured":"Sharma RR, Pollock K, Hubel A, McKenna D. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion. 2014;54(5):1418\u201337.","journal-title":"Transfusion."},{"issue":"4","key":"1623_CR39","doi-asserted-by":"publisher","first-page":"e0176120","DOI":"10.1371\/journal.pone.0176120","volume":"12","author":"J Wang","year":"2017","unstructured":"Wang J, Wei Y, Zhao S, Zhou Y, He W, Zhang Y, et al. The analysis of viability for mammalian cells treated at different temperatures and its application in cell shipment. PLoS One. 2017;12(4):e0176120.","journal-title":"PLoS One"},{"issue":"7","key":"1623_CR40","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/j.1537-2995.2009.02138.x","volume":"49","author":"TA Lane","year":"2009","unstructured":"Lane TA, Garls D, Mackintosh E, Kohli S, Cramer SC. Liquid storage of marrow stromal cells. Transfusion. 2009;49(7):1471\u201381.","journal-title":"Transfusion."},{"issue":"6","key":"1623_CR41","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1089\/ten.2006.12.1711","volume":"12","author":"K Muraki","year":"2006","unstructured":"Muraki K, Hirose M, Kotobuki N, Kato Y, Machida H, Takakura Y, et al. Assessment of viability and osteogenic ability of human mesenchymal stem cells after being stored in suspension for clinical transplantation. Tissue Eng. 2006;12(6):1711\u20139.","journal-title":"Tissue Eng"},{"issue":"9","key":"1623_CR42","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.cellbi.2007.03.010","volume":"31","author":"F Cobo","year":"2007","unstructured":"Cobo F, Cortes JL, Cabrera C, Nieto A, Concha A. Microbiological contamination in stem cell cultures. Cell Biol Int. 2007;31(9):991\u20135.","journal-title":"Cell Biol Int"},{"issue":"3","key":"1623_CR43","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0300-9785(85)80037-5","volume":"14","author":"IM Lundstrom","year":"1985","unstructured":"Lundstrom IM. Serum immunoglobulins and autoantibodies in patients with oral lichen planus. Int J Oral Surg. 1985;14(3):259\u201368.","journal-title":"Int J Oral Surg"},{"issue":"2","key":"1623_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/0973-029X.84474","volume":"15","author":"N Lavanya","year":"2011","unstructured":"Lavanya N, Jayanthi P, Rao UK, Ranganathan K. Oral lichen planus: an update on pathogenesis and treatment. J Oral Maxillofac Pathol. 2011;15(2):127\u201332.","journal-title":"J Oral Maxillofac Pathol"},{"issue":"4","key":"1623_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jcpa.2010.09.173","volume":"144","author":"R Harley","year":"2011","unstructured":"Harley R, Gruffydd-Jones TJ, Day MJ. Immunohistochemical characterization of oral mucosal lesions in cats with chronic gingivostomatitis. J Comp Pathol. 2011;144(4):239\u201350.","journal-title":"J Comp Pathol"},{"issue":"12","key":"1623_CR46","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.jcyt.2013.06.009","volume":"15","author":"SA Park","year":"2013","unstructured":"Park SA, Reilly CM, Wood JA, Chung DJ, Carrade DD, Deremer SL, et al. Safety and immunomodulatory effects of allogeneic canine adipose-derived mesenchymal stromal cells transplanted into the region of the lacrimal gland, the gland of the third eyelid and the knee joint. Cytotherapy. 2013;15(12):1498\u2013510.","journal-title":"Cytotherapy."},{"key":"1623_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13287-015-0050-0","volume":"6","author":"A Kol","year":"2015","unstructured":"Kol A, Wood JA, Carrade Holt DD, Gillette JA, Bohannon-Worsley LK, Puchalski SM, et al. Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses. Stem Cell Res Ther. 2015;6:73.","journal-title":"Stem Cell Res Ther"},{"issue":"1\u20132","key":"1623_CR48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0165-2427(92)90132-A","volume":"35","author":"R Lehmann","year":"1992","unstructured":"Lehmann R, von Beust B, Niederer E, Condrau MA, Fierz W, Aubert A, et al. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus. Vet Immunol Immunopathol. 1992;35(1\u20132):199\u2013214.","journal-title":"Vet Immunol Immunopathol"},{"issue":"5","key":"1623_CR49","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1086\/315089","volume":"180","author":"DH Gebhard","year":"1999","unstructured":"Gebhard DH, Dow JL, Childers TA, Alvelo JI, Tompkins MB, Tompkins WA. Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats. J Infect Dis. 1999;180(5):1503\u201313.","journal-title":"J Infect Dis"},{"issue":"3","key":"1623_CR50","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1046\/j.1365-2567.2003.01590.x","volume":"108","author":"A Trautmann","year":"2003","unstructured":"Trautmann A, Ruckert B, Schmid-Grendelmeier P, Niederer E, Brocker EB, Blaser K, et al. Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic\/effector subpopulation. Immunology. 2003;108(3):305\u201312.","journal-title":"Immunology."},{"issue":"3","key":"1623_CR51","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.4049\/jimmunol.180.3.1800","volume":"180","author":"F Caprioli","year":"2008","unstructured":"Caprioli F, Sarra M, Caruso R, Stolfi C, Fina D, Sica G, et al. Autocrine regulation of IL-21 production in human T lymphocytes. J Immunol. 2008;180(3):1800\u20137.","journal-title":"J Immunol"},{"issue":"21","key":"1623_CR52","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1089\/scd.2013.0193","volume":"22","author":"MJ Hoogduijn","year":"2013","unstructured":"Hoogduijn MJ, Roemeling-van Rhijn M, Engela AU, Korevaar SS, Mensah FK, Franquesa M, et al. Mesenchymal stem cells induce an inflammatory response after intravenous infusion. Stem Cells Dev. 2013;22(21):2825\u201335.","journal-title":"Stem Cells Dev"},{"issue":"7152","key":"1623_CR53","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature05969","volume":"448","author":"R Nurieva","year":"2007","unstructured":"Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 2007;448(7152):480\u20133.","journal-title":"Nature."},{"key":"1623_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fvets.2016.00054","volume":"3","author":"JN Winer","year":"2016","unstructured":"Winer JN, Arzi B, Verstraete FJ. Therapeutic management of feline chronic gingivostomatitis: a systematic review of the literature. Front Vet Sci. 2016;3:54.","journal-title":"Front Vet Sci."},{"issue":"2","key":"1623_CR55","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12015-013-9492-x","volume":"10","author":"J Ge","year":"2014","unstructured":"Ge J, Guo L, Wang S, Zhang Y, Cai T, Zhao RC, et al. The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke. Stem Cell Rev. 2014;10(2):295\u2013303.","journal-title":"Stem Cell Rev"},{"key":"1623_CR56","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fneur.2015.00155","volume":"6","author":"J Boltze","year":"2015","unstructured":"Boltze J, Arnold A, Walczak P, Jolkkonen J, Cui L, Wagner DC. The dark side of the force - constraints and complications of cell therapies for stroke. Front Neurol. 2015;6:155.","journal-title":"Front Neurol"},{"issue":"9","key":"1623_CR57","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/eurheartj\/ehi818","volume":"27","author":"T Freyman","year":"2006","unstructured":"Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006;27(9):1114\u201322.","journal-title":"Eur Heart J"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01623-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-020-01623-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01623-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T19:14:14Z","timestamp":1615576454000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01623-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,13]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1623"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01623-9","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,13]]},"assertion":[{"value":"11 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted with approval of the Institutional Animal Care and Use Committees at the University of California, Davis, and at Cornell University, and the Clinical Trials Review Board of the University of California, Davis. All cat owners signed an informed consent prior to enrollment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}